ZIOPHARM Oncology to Host First-Quarter 2017 Financial Results and Corporate Update Conference Call on May 1, 2017 at 4:30 p....
April 24 2017 - 07:00AM
ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company
focused on new immunotherapies, today announced that it will host a
conference call and webcast slide presentation on Monday, May 1,
2017 at 4:30 p.m. ET to provide a corporate update and discuss
financial results for the first quarter ended March 31, 2017.
The call can be accessed by dialing
1-844-309-0618 (U.S. and Canada) or 1-661-378-9465 (international).
The passcode for the conference call is 8375689. To access the
slides and live webcast or the subsequent archived recording, visit
the “Investors & Media” section of the ZIOPHARM website at
www.ziopharm.com. The webcast will be recorded and available for
replay on the Company’s website for two weeks.
About ZIOPHARM Oncology,
Inc.:
ZIOPHARM Oncology is a Boston,
Massachusetts-based biotechnology company employing novel gene
expression, control and cell technologies to deliver safe,
effective and scalable cell- and viral-based therapies for the
treatment of cancer and graft-versus-host-disease. The Company's
immuno-oncology programs, in collaboration with Intrexon
Corporation (NYSE:XON) and the MD Anderson Cancer Center, include
chimeric antigen receptor T cell (CAR-T) and other adoptive
cell-based approaches that use non-viral gene transfer methods for
broad scalability. The Company is advancing programs in multiple
stages of development together with Intrexon Corporation's
RheoSwitch Therapeutic System® technology, a switch to turn on and
off, and precisely modulate, gene expression in order to improve
therapeutic index. The Company's pipeline includes a number of
cell-based therapeutics in both clinical and preclinical testing,
which are focused on hematologic and solid tumor malignancies.
Contact:
Amy Trevvett
Vice President, Corporate Communications and Investor Relations
617-502-1881
atrevvett@ziopharm.com
David Pitts
Argot Partners
212-600-1902
david@argotpartners.com
Intrexon (NASDAQ:XON)
Historical Stock Chart
From Feb 2024 to Mar 2024
Intrexon (NASDAQ:XON)
Historical Stock Chart
From Mar 2023 to Mar 2024